Literature DB >> 25758434

Familial C3 glomerulonephritis associated with mutations in the gene for complement factor B.

Hideaki Imamura1, Takao Konomoto1, Etsuko Tanaka2, Satoshi Hisano3, Yoko Yoshida4, Yoshihiro Fujimura4, Toshiyuki Miyata5, Hiroyuki Nunoi2.   

Abstract

We report the first case of familial C3 glomerulonephritis (C3GN) associated with mutations in the gene for complement factor B (CFB). A 12-year-old girl was diagnosed with biopsy-proven C3GN. Her mother had a history of treatment for membranoproliferative glomerulonephritis, and her brother had hypocomplementemia without urinary abnormalities. DNA analysis revealed heterozygosity for CFB p.S367R in the patient, mother and brother. Evaluation of the structure-function relationship supports that this mutation has gain-of-function effects in CFB. The present case suggests that CFB has an important role in the etiology of C3GN and provides a new insight into anticomplement therapy approaches.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  C3 glomerulonephritis; complement alternative pathway; complement factor B; genetic mutation

Mesh:

Substances:

Year:  2015        PMID: 25758434     DOI: 10.1093/ndt/gfv054

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  13 in total

Review 1.  Complement and the Kidney: An Overview.

Authors:  Joshua M Thurman
Journal:  Adv Chronic Kidney Dis       Date:  2020-03       Impact factor: 3.620

2.  Rare genetic variant in the CFB gene presenting as atypical hemolytic uremic syndrome and immune complex diffuse membranoproliferative glomerulonephritis, with crescents, successfully treated with eculizumab.

Authors:  Khalid Alfakeeh; Mohammed Azar; Majid Alfadhel; Alsuayri Mansour Abdullah; Nourah Aloudah; Khaled O Alsaad
Journal:  Pediatr Nephrol       Date:  2017-02-16       Impact factor: 3.714

Review 3.  C3 Glomerulopathy.

Authors:  Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-04-07       Impact factor: 3.714

Review 4.  A clinical approach to children with C3 glomerulopathy.

Authors:  Marina Vivarelli; Nicole van de Kar; Raffaella Labbadia; Francesca Diomedi-Camassei; Joshua M Thurman
Journal:  Pediatr Nephrol       Date:  2021-05-18       Impact factor: 3.714

5.  Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis.

Authors:  Sigridur Sunna Aradottir; Ann-Charlotte Kristoffersson; Lubka T Roumenina; Anna Bjerre; Pavlos Kashioulis; Runolfur Palsson; Diana Karpman
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

Review 6.  C3 glomerulopathy and current dilemmas.

Authors:  Naoko Ito; Ryuji Ohashi; Michio Nagata
Journal:  Clin Exp Nephrol       Date:  2016-11-23       Impact factor: 2.801

Review 7.  Diseases of complement dysregulation-an overview.

Authors:  Edwin K S Wong; David Kavanagh
Journal:  Semin Immunopathol       Date:  2018-01-11       Impact factor: 9.623

8.  Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome.

Authors:  Yuzhou Zhang; Robin A Kremsdorf; C John Sperati; Kammi J Henriksen; Mari Mori; Renee X Goodfellow; Gabriella R Pitcher; Cindy L Benson; Nicolo Ghiringhelli Borsa; Ronald P Taylor; Carla M Nester; Richard J H Smith
Journal:  Kidney Int       Date:  2020-06-12       Impact factor: 10.612

9.  Combination of a Novel Genetic Variant in CFB Gene and a Pathogenic Variant in COL4A5 Gene in a Sibling Renal Disease: A Case Report.

Authors:  Feng-Mei Wang; Yan Yang; Xiao-Liang Zhang; Yan-Li Wang; Yan Tu; Bi-Cheng Liu; Bin Wang
Journal:  Front Genet       Date:  2021-07-19       Impact factor: 4.599

Review 10.  Update on genetics and diabetic retinopathy.

Authors:  Blake M Hampton; Stephen G Schwartz; Milam A Brantley; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.